FFHP Plus Thick Membranes
A thicker and large-pore back nitrocellulose membrane with added surfactant (235 µm thick).
Advancement of lateral-flow assays
The simplicity, ease-of-use, and low cost of lateral flow assays (LFAs) are drivers for the continued growth of this type of rapid test. Requiring a specialized set of membranes and pads, including a sample pad or blood separator, conjugate release pad, nitrocellulose membrane, and absorption pad, research groups continue to optimize the sensitivity of POC testing. Many lateral flow immunoassays have been developed for a wide range of analytes including biomarkers for cardiac failure, cancer, infectious diseases, and foodborne pathogens and toxins. Modification of nitrocellulose membranes and the addition of signal amplification pads have successfully improved test sensitivity.
Interactive brochure: With you every step of the assay
Using a single supplier for multiple components across a lateral flow test and one who can also support your workflow from idea and prototype to commercialization can help streamline your activities and accelerate assay development and commercialization. Here's how we can help!
Infographic: Considerations for membrane selection
Remind yourself of the key considerations for membrane selection to meet your goals for test sensitivity, specificity, and duration no matter your choice of reagents, sample, or application.
Checklist: 10 top tips for lateral flow assay development
When designing your own lateral flow assay, there are several variables to consider including choice of detection reagents, assay materials, and manufacturing methods. Use this checklist to review ten important considerations when developing your LFA, which we hope will give you a deeper insight into lateral flow assays to streamline your development process.
Diagnostic Services
Helping you build and accelerate the development of smarter molecular and immunodiagnostic assays
Development of molecular assays for POC environments
Components and services to support molecular assay development in point-of-care settings
Immunodiagnostics in the laboratory environment
Antibody, protein enrichment and purification technologies to facilitate immunoassays
